MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ELVN has $464,852K in assets. $11,487K in debts. $132,184K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
4031.84%
Quick Ratio
4031.84%
Cash Ratio
1150.73%
Debt to Asset Ratio
2.47%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
132,184 98,896 101,732 119,437
Marketable securities
320,217 363,725 375,833 371,066
Restricted cash
-0 0 0
Prepaid expenses and other current assets
10,736 12,257 5,118 5,119
Total current assets
463,137 474,878 482,683 495,622
Property and equipment, gross
--1,535 -
Less accumulated depreciation
--1,136 -
Property and equipment, net
20 34 399 462
Operating lease right-of-use assets
290 383 475 564
Deferred offering costs
217 217 217 -
Other long-term assets
1,188 656 7,101 7,239
Total assets
464,852 476,168 490,875 503,887
Accounts payable
1,640 2,159 1,429 2,351
Accrued expenses and other current liabilities
9,847 14,409 13,221 12,860
Total current liabilities
11,487 16,568 14,650 15,211
Long-term liabilities
--103 204
Total liabilities
11,487 16,568 14,753 15,415
Common stock, par value 0.001 authorized shares - 100,000,000 issued and outstanding shares - 60,889,655 and 59,440,045 at march 31, 2026 and december 31, 2025, respectively
61 59 59 59
Additional paid-in capital
824,479 806,373 793,341 785,941
Accumulated other comprehensive (loss) income
-382 334 221 -177
Accumulated deficit
-370,793 -347,166 -317,499 -297,351
Total stockholders' equity
453,365 459,600 476,122 488,472
Total liabilities and stockholders' equity
464,852 476,168 490,875 503,887
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$320,217K Cash and cashequivalents$132,184K Prepaid expenses andother current assets$10,736K Total current assets$463,137K Other long-termassets$1,188K Operating leaseright-of-use assets$290K Deferred offering costs$217K Property and equipment,net$20K Total assets$464,852K Total liabilities andstockholders' equity$464,852K Total stockholders'equity$453,365K Total liabilities$11,487K Accumulated deficit-$370,793K Accumulated othercomprehensive (loss) income-$382K Additional paid-in capital$824,479K Total currentliabilities$11,487K Common stock, par value0.001 authorized...$61K Accrued expenses andother current...$9,847K Accounts payable$1,640K

Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics, Inc. (ELVN)